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Abstract
Background: Since activation of the PI3K/(protein kinase B; PKB/akt) pathway has been shown to alter muscle mass and
growth, the aim of this study was to determine whether resistance exercise increased insulin like growth factor (IGF) I/
phosphoinositide 3-kinase (PI3K) signalling and whether altering PI(3,4,5)P3 metabolism genetically would increase load
induced muscle growth.
Methodology/Principal Findings: Acute and chronic resistance exercise in wild type and muscle specific PTEN knockout
mice were used to address the role of PI(3,4,5)P3 regulation in the development of skeletal muscle hypertrophy. Acute
resistance exercise did not increase either IGF-1 receptor phosphorylation or IRS1/2 associated p85. Since insulin/IGF
signalling to PI3K was unchanged, we next sought to determine whether inactivation of PTEN played a role in load-induced
muscle growth. Muscle specific knockout of PTEN resulted in small but significant increases in heart (PTEN+/+ =
5.0060.02 mg/g, PTEN2/2 = 5.5060.09 mg/g), and TA (PTEN+/+ = 1.7460.04 mg/g, PTEN2/2 = 1.89 60.03) muscle mass,
while the GTN, SOL, EDL and PLN remain unchanged. Following ablation, hypertrophy of the PLN, SOL or EDL muscles was
similar between PTEN2/2 and PTEN+/+ animals. Even though there were some changes in overload-induced PKB and S6K1
phosphorylation, 1 hr following acute resistance exercise there was no difference in the phosphorylation state of S6K1
Thr389 between genotypes.
Conclusions/Significance: These data suggest that physiological loading does not lead to the enhanced activation of the
PI3K/PKB/mTORC1 axis and that neither PI3K activation nor PTEN, and by extension PI(3,4,5)P3 levels, play a significant role
in adult skeletal muscle growth.
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Introduction
The development of skeletal muscle mass and function is
dependent upon signalling through the insulin like growth factor
(IGF)/protein kinase B (PKB/akt)/mammalian target of rapamy-
cin complex 1 (mTORC1) axis [1,2,3]. Deletion or inhibition of
components of this axis leads to smaller muscles [4,5] and
impaired hypertrophy in response to loading [6], regeneration [7]
and growth factor stimulation [5,8,9]. In contrast, over-expression
of various components of this pathway leads to muscle growth
[7,10,11] and protection from atrophy [6,12,13].
Growth factors, such as IGF-1, activate receptor tyrosine
kinases leading to the membrane recruitment and activation of
the class 1a phosphatidylinositol 3-kinase (PI3K) [14,15]. At the
membrane, PI3K phosphorylates PI(4,5)P2 at the D3 position on
the inositol ring producing PI(3,4,5)P3 [16], an important second
messenger required for the oncogenic [17] and growth factor [18]
induced activation of mTORC1. PI(3,4,5)P3 activates mTORC1
through the recruitment and activation of PKB [19]. PKB is an
important cellular mediator of growth factor signalling with
cellular roles including regulation of cell survival, growth,
proliferation, angiogenesis and metabolism [20]. A clear role for
PKB in controlling skeletal muscle mass has been defined with a
range of genetic techniques combined with in vivo and in vitro
studies. Electroporating constitutively active PKB in to adult rat
skeletal muscle increases muscle mass and protects against
unloading/denervation induced atrophy [6,7], overexpressing
constitutively active PKB in C2C12 myotubes increases myotube
diameter [8] and in both instances these effects are antagonised by
PI(3,4,5)P3 phosphatases [6,8].
In skeletal muscle, enhanced PI3K expression or downstream
signalling promotes myoblast differentiation [21] and skeletal
muscle growth [6,7] but does not result in transformation of
terminally differentiated skeletal muscle [22,23]. Due to the
growth promoting effects of PI(3,4,5)P3, the amount of this
phospholipid is tightly controlled by several lipid phosphatases
including the SH2-containing 59-inositol phosphatase (SHIP) 2
[16] and PTEN. Whereas SHIP2 removes the 5-phosphate, PTEN
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is the only enzyme capable of directly antagonising PI3K by
dephosphorylating the D3 phosphate of PI(3,4,5)P3 [24,25].
As with PI3K, PTEN plays an important role in many cellular
functions such as cell migration [26], PDGF induced membrane
ruffling [27], IGF-1/insulin sensitivity [28] and oncogenesis [29].
In many instances loss of PTEN leads to enhanced tumour
formation [30]. However, loss of PTEN in striated muscle does not
lead to transformation [22,23]. Interestingly, striated muscle
specific PTEN null mice have been reported to have a ,50%
increase in heart mass [22] and are protected from high fat diet
induced insulin resistance and diabetes [23] even though at
baseline they showed a slight reduction in insulin stimulated PKB
Thr308 phosphorylation [23].
Since the activation of the PI3K signalling pathway leads to
muscle growth, the aim of the current work was to determine
whether growth factor signalling through PI3K was induced by
resistance exercise and whether genetic deletion of PTEN would
enhance the hypertrophic response of muscle to overload and
acute resistance exercise. We hypothesised that muscle specific loss
of PTEN would lead to blunted insulin stimulated PKB
phosphorylation but enhanced muscle hypertrophy and hypertro-
phic signalling following synergist ablation and acute resistance
exercise.
Methods
Materials
Rabbit anti-S6K1 was obtained from Santa Cruz Biotechnology
(California, USA), rabbit-anti: p-S6K1T389, p-PKBT308, t-PKB,
were from Cell Signalling Technologies (Massachusetts, USA). All
other chemicals were from Sigma-Aldrich unless stated otherwise.
Animals
All procedures were approved by the University of Dundee
research ethics committee and performed under UK Home Office
project licence number 60/3441. Surgical and collection proce-
dures on transgenic mice ,20–35 g took place under inhaled
anaesthetic using a 2.5% concentration of isoflurane. Animals
were allowed to recover for the appropriate time period post
stimulation and were terminated after muscle collection under
anaesthesia.
Generation of Muscle Specific PTEN null mice
The generation of MCK-Cre mice and PTEN Floxed mice
have previously been described [31,32]. PTEN flox/flox mice
were a kind gift from Professor Doreen Cantrell University of
Dundee and the MCK-Cre+/2 mice were a kind gift from
Professor Dario Alessi University of Dundee. The MCK-Cre and
PTEN flox/flox mice were mated and the subsequent offspring
were then used as breeders to generate MCK-Cre controls termed
PTEN+/+ (PTEN+/+ MCK-Cre+/2), muscle specific PTEN null
mice termed PTEN2/2 (PTEN flox/flox MCK-Cre+/2), PTEN
flox controls (PTEN flox/flox MCK-Cre2/2) and wild types
(PTEN+/+ MCK-Cre2/2). All genotyping was performed by
PCR using genomic DNA isolated from the tail tip of 3-to-4-week-
old mice. Genotyping was then repeated on skeletal muscle DNA
from experimental animals to confirm that experimental animals
were of the correct genotype. The primers for identifying carriers
of the MCK-Cre transgene (59-ATGTCCAATTTACTGACCG-
39 and 59-CGCCGCATAACCAGTGAAAC-39) were used under
the following conditions: 1 cycle of 94uC for 2 min, 39 cycles of
92uC for 30 s, 50uC for 30 s, and 72uC for 45 s followed by one
cycle of 72uC for 10 min. The primers for identifying carriers of
the PTEN flox transgene (59- GCCTTACCTAGTAAAGCAAG -
39 and 59- GGC AAA GAA TCT TGG TGT TAC -39) were used
under the following conditions: 1 cycle of 94uC for 3 min 35 cycles
of 94uC for 30 s, 53uC for 40 s, and 72uC for 35 s followed by one
cycle of 72uC for 10 min. PCR products were then subjected to
electrophoresis on a 2% agarose gel and genotype was established
by the presence of a 500 bp band from the MCK-Cre reaction
and either a 200 bp product for PTEN2/2 animals and a 250 bp
product for PTEN+/+ animals with a double band for
heterozygotes (Figure S1).
Acute Electrical Stimulation
The resistance exercise model was performed as described
previously [33]. Tetanic contractions were elicited using a Grass
stimulator at a frequency of 100 Hz, 6–12 V, 1 ms duration, 9 ms
delay for 10 sets of 6 repetitions. Each repetition lasted 2 s, a 10 s
recovery was permitted between repetitions, and a 1 min recovery
was allowed between sets of 6 repetitions resulting in a 20 min
stimulation protocol. Following the acute bout of contractions,
stimulated and contralateral muscles were rapidly removed, snap
frozen in liquid nitrogen, and stored at 280uC until processed.
Load Induced Hypertrophy
In order to study the overload induced growth response of
skeletal muscle from muscle specific PTEN null mice three
different muscles were overloaded. The plantaris (PLN) and soleus
(SOL) muscles were overloaded by removal of the gastrocnemius
(GTN) muscle and in a separate group of animals the extensor
digitorum longus (EDL) muscle was overloaded by removal of the
tibialis anterior muscle. The different models were chosen as
models of continuous overload (PLN and SOL) with (PLN) or
without (SOL) changes in recruitment and an intermittent
overload model (EDL). The continuous and intermittent models
were used in case the loss of PTEN resulted in a prolonged signal
for muscle growth that was obscured in the continuous overload
paradigm. After a pilot study, the following protocol was
established: ablation of the GTN for 10 days to induce
hypertrophy of the PLN and SOL; and in a separate group of
animals ablation of the TA for 4 weeks to induce hypertrophy in
the EDL. The synergist ablation model was performed as
described previously [34]. Briefly animals were anaesthetised and
the area above the incision shaved and sterilised. The GTN was
isolated and severed at the Achilles tendon and the distal two
thirds of the GTN removed leaving the PLN and SOL muscles
and their blood and nerve supply intact. A similar procedure was
carried out for removal of the tibialis anterior (TA) except the TA
was removed in totem whilst leaving the EDL intact. The
overlying skin and fascia were sutured separately and the animal
was then moved to a temperature-controlled environment to
recover. All animals returned to normal activity within one hour.
In the recovery period prior to collection animals were monitored
on a daily basis for signs of pain or post-operative infection. No
signs of discomfort or distress were noted. On the day of collection,
animals were anaesthetised and overloaded and contralateral
control muscles were rapidly removed rinsed in PBS, all
connective/scar tissue was removed using a dissection microscope,
then the muscles were snap frozen in liquid nitrogen, and stored at
280uC until processed. Following collection animals were
terminated by cervical dislocation.
Protein Extraction and quantification
Muscles were rapidly removed and rinsed to remove blood and
fur. Tissue was snap frozen in liquid nitrogen and stored at
280uC. For processing, muscle was powdered on dry ice using a
mortar and pestle and polytron homogenised in 10-fold mass
PIP3-Independent Hypertrophy
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excess of ice cold sucrose lysis buffer (50 mM Tris pH 7.5,
250 mM Sucrose, 1 mM EDTA, 1 mM EGTA, 1% Triton X
100, 50 mM NaF, 1 mM NaVO4 Na2(PO4)2 and 0.1% DTT).
This was briefly vortexed and centrifuged at 4uC for 10 mins at
11,000 rpm to remove insoluble material. Protein concentrations
were determined using the DC protein assay (Bio-Rad, Hercules;
California, USA).
Western Blotting
Equal aliquots of protein were diluted in Laemmli sample buffer
and boiled for 5 mins. 5–10 mg of sample was then subjected to
SDS-PAGE on 10% acrylamide gels at a constant current equal to
20 mA per gel and transferred to Protran nitrocellulose membrane
(Whatman; Dassel, Germany) using a BioRad semidry transfer
apparatus at 100 V for 1 hour. Membranes were blocked in 5%
dry milk in TBS-T and then incubated over night at 4uC with
appropriate primary antibody in TBST at 1:1000. The mem-
branes were then washed 3x in TBST before incubation for
1 hour at room temperature with peroxidase-conjugated second-
ary antibodies in TBST at 1:10000 (Perbio Science; Cramlington,
UK). Antibody binding was detected using an enhanced
chemiluminescence HRP substrate detection kit (Millipore;
Watford, UK). Imaging and band quantification were carried
out using a Chemi Genius Bioimaging Gel Doc System (Syngene;
Cambridge, UK).
Immunocytochemistry
PLN muscles were rapidly dissected, rinsed in PBS and blotted
dry before being mounted in Tissue Tek OCT compound (Sakura
Finetek, Japan) and frozen in liquid nitrogen cooled isopentane.
Tissues were sectioned 8 mm thick at 220uC onto glass coverslips.
Coverslips were then rinsed 3 times in PBS and fixed in 4% PFA-
PBS, aldehydes were quenched in 100 mM glycine for 15 mins
before rinsing 3 times in 0.2% fish skin gelatine (made in PBS).
Coverslips were then blocked in Goat Serum (1:10, 0.2% FSG;
Jackson ImmunoResearch Europe; Suffolk, UK) for 10 mins, and
rinsed once in 0.2% FSG before being incubated in rabbit anti-
PTEN (1:100), for 20 mins at room temperature. Primary was
rinsed 3 times with 0.2% FSG before being placed in secondary
[goat anti-rabbit Alexa Fluor 594 (Invitrogen; California, USA) at
1:500, with DAPI at 1:1000 using an 10 mg/ml stock]. Secondary
was rinsed off 3 times with 0.2% FSG and 3 times in MiliQ water
before being blotted dry and mounted in VectashieldH Mounting
Medium (Vector Laboratories; California, USA). Sections were
analyzed on a Deltavision DV3 wide field deconvolution
microscope.
Muscle Fibre Isolation
Muscle fibres were isolated using a protocol described
previously [35,36]. Briefly, 6 PLN muscles from each experimental
group were grouped and incubated for 4 h at 37uC in a culture
medium containing minimum essential medium with Earle’s salt
and L-glutamine (GIBCO; California, USA) supplemented with
10% fetal bovine serum (GIBCO; California, USA), 0.2% type I
collagenase, 100 U/ml penicillin, and 100 mg/ml streptomycin
(GIBCO; California, USA). Fibers were separated from connective
tissue by fine tweezers under a dissecting microscope and subjected
to tissue lysis as previously described.
Insulin Responsiveness
Animals were anaesthetised in groups of 3 as previously
described and maintained in an anaesthetic chamber. Fast acting
human insulin (Actrapid, Novo Nordisk; Bagsvaerd, Denmark)
(0.1, 1, 10, 100, or 1000 mU/g), diluted in sterile 0.2% BSA-PBS,
was injected intraperitoneally into an animal. Controls were
injected with an equal volume of 0.2% BSA-PBS. The
concentration of each dose was adjusted such that each animal
was injected with 10 ml/g body weight. Following 10 mins of
insulin stimulation, animals were terminated by cervical disloca-
tion and EDL and SOL muscles were rapidly removed, rinsed in
PBS and snap frozen in liquid nitrogen before being stored at
280uC.
Statistics
Data are given as mean 6 SEM values with a minimum n of 3.
Statistical significance (p,0.05 unless otherwise stated) of the data
was determined by Student’s T-test or a single factor ANOVA
with posthoc analysis using Tukey’s honestly significant difference
test.
Results
Resistance exercise does not increase IGF-1 receptor
phosphorylation
Since the anabolic affects of insulin and IGF-1 are mediated
through the IGF-1R, we determined the tyrosine phosphorylation
of the IGF-1R following uniaxial resistance exercise by immuno-
precipitating the receptor and determining phosphotyrosine
content by western blot. At no time point following acute
resistance exercise was there an increase in IGF-1R tyrosine
phosphorylation (Figure 1), suggesting that the IGF-1R is not
activated by acute resistance exercise.
Figure 1. The IGF-1 receptor is not tyrosine phosphorylated
following a single bout of resistance exercise. immunoblots. The
IGF-1R was immunoprecipitated from the right and left TA muscles
(n = 3) following resistance exercise and the resulting western blot was
probed with the pY20 phosphotyrosine antibody (A) and the
immunoreactivity was quantified in panel (B).
doi:10.1371/journal.pone.0011624.g001
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Resistance exercise does not increase IRS1/2 and pY
associated p85
The second step in the activation of mTORC1 by growth factors is
the recruitment of IRS1/2 and PI3K to the receptor. Therefore, we
next sought to determine whether there was a change in IRS1/2
associated p85 after resistance exercise. Insulin potently increased the
amount of IRS1/2 associated p85 (Figure 2). However, at no time
after resistance exercise was there an increase in IRS1/2 associated
p85 (Figure 2). In fact, IRS1 associated p85 was significantly reduced
at 0.5 hr (257.168.9%) and 3 hr (255.967.8%) and IRS2
associated p85 was significantly reduced at 0.5 hr (255.169.9%).
There was also no significant change in phosphotyrosine-associated
p85 at 0 hr, 0.5 hrs or 18 hrs post contraction (Figure 2).
Genotyping and PTEN Tissue Distribution
Since PI3K was not activated following resistance exercise, we
next sought to determine whether this pathway was increased due
to inactivation of the 3-phosphatase PTEN. Muscle specific PTEN
null mice were confirmed by the presence of the 500 bp MCK-
Cre PCR product in conjunction with a single 250 bp product
from the PTEN flox PCR reaction, while MCK-Cre controls were
confirmed by the presence of a 200 bp product from the Cre PCR
reaction (Figure S1). As expected from the wide range of tissues
affected by germline PTEN mutations [37,38,39], PTEN was
highly expressed in all tissues analysed with the exception of
skeletal muscle (Figure S1). Surprisingly PTEN2/2 mice did not
demonstrate a complete knockout in skeletal or cardiac muscle,
directly contrasting previously published observations [22,23]. To
confirm muscle specific knockout of PTEN we analysed the
expression of PTEN in whole brain/kidney/PLN lysates, isolated
thymocytes and isolated PLN muscle fibres. As a positive control
for the function of the Cre-loxP system in our line we also ran
lysates from isolated thymocytes expressing Cre under the control
of the LCK (thymocyte-specific) promoter. Again, PTEN
Figure 2. IRS1/2 and pY associated p85 is unchanged following a single bout of resistance exercise. IRS1, IRS2, or phosphotyrosine
containing proteins were immunoprecipitated from the right and left TA muscles (n = 4) following resistance exercise and the resulting western blot
(A) was probed with the antibody to the p85 regulatory subunit of PI3K and the immunoreactivity was quantified in panel (B). * Indicates significantly
different from control leg.
doi:10.1371/journal.pone.0011624.g002
PIP3-Independent Hypertrophy
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expression in skeletal muscle was significantly lower than brain,
kidney, or isolated thymocytes. As described above, there was a
partial knockout of PTEN in the whole PLN muscle, however the
remaining level of PTEN was higher than in the PTEN2/2
thymocytes. In the isolated muscle fibres, expression of PTEN was
extremely low in the PTEN+/+ animals and was reduced in the
PTEN2/2 animals to the same extent as seen in the PTEN2/2
thymocytes (Figure S1). We next determined the expression of
PTEN in skeletal muscle using immunohistochemistry. Again, we
were unable to detect significant amounts of PTEN in skeletal
muscle fibres of either PTEN+/+ or PTEN2/2 animals. PTEN
positive areas were seen between muscle fibres in both PTEN+/+
and PTEN2/2 muscles, suggesting that PTEN was largely
restricted to cells of endothelial origin. This suggests that the
PTEN detected by western blot in the PTEN2/2 muscle is from
vascular endothelial, neural and blood cells all of which are rich in
PTEN.
Skeletal and Cardiac Muscle Mass
To assess the effect of PTEN ablation on skeletal and cardiac
muscle mass we determined the wet mass of a wide range of skeletal
muscles and the heart of a large number of animals [PTEN2/2
n = 20 (10 male +10 female), PTEN+/+ n = 19 (9 male +10 female)]
(Figure 3). Similar to previous observations [23] the mass of the
GTN, SOL, EDL, and PLN muscles were unaffected by the loss
of PTEN (Figure 3). However, the TA [(8%) PTEN+/+ =
1.7460.04 mg/g, PTEN2/2 = 1.8960.03 (p,0.05)] muscles were
significantly larger in the PTEN2/2 mice. As has been reported, the
heart mass was increased (Figure 3), though the magnitude of the
effect was less (,10%) than seen previously (,50%); [22].
Insulin Responsiveness
Several reports have demonstrated a loss of insulin sensitivity
following PTEN ablation [23,28]. To confirm PTEN knockout in
our mice, a dose response curve for insulin stimulated PKB Thr308
phosphorylation was performed (Figure S2). In the SOL muscle,
there was no effect of PTEN ablation on insulin stimulated PKB
Thr308 phosphorylation (Figure S2). However, although the
maximal response of the EDL was unaltered, there was a right
shift in the curve suggesting impaired insulin-stimulated phos-
phorylation of PKB (Figure S2).
Muscle Growth Response Following Ablation
After confirming a functional knockout of PTEN, the GTN or the
TA muscle was removed from separate groups of mice to overload
the PLN and SOL, or EDL muscle, respectively (Figure 4). Ablation
of the synergists induced a significant hypertrophy in all of the
muscles analysed (PLN = 57.06618.04%, SOL = 38.26615.27%,
EDL = 33.7465.64%; p,0.05). However, there was no significant
difference between the hypertrophy responses of the PTEN2/2 and
PTEN+/+ animals (PLN = 61.41619.42%, SOL = 50.536
12.79%, EDL = 29.2063.75% (p,0.05); Figure 4).
Activation of Growth Signals Following Ablation
Overload results in prolonged activation of the Class 1a PI3K
[40]. Thus we anticipated that ablation of PTEN would lead to
even greater accumulation of PI(3,4,5)P3 and therefore enhanced
PKB phosphorylation at the PI(3,4,5)P3 sensitive site, Thr
308
(Figure 5). In the PLN of the PTEN+/+ mice, there was no net
change in relative PKB Thr308 phosphorylation due to an increase
in total PKB. However, in the PLN of PTEN2/2 animals the
relative phosphorylation of PKB at Thr308 was significantly
enhanced due to an increase in phosphorylation not a decrease
in total protein (PTEN+/+ - Con PLN = 1.2160.32, Abl
PLN = 1.8360.70; PTEN2/2 - Con PLN = 0.7860.14, Abl
PLN = 7.2461.28). The increase in PKB phosphorylation was
similar in the EDL and SOL muscles of the PTEN2/2 and
PTEN+/+ animals following ablation.
Thr1462 of TSC2 is known to be directly phosphorylated by
PKB leading to the destabilisation of the TSC1/2 complex and
activation of mTORC1 [41]. Therefore, we hypothesised that
overload would lead to increased phosphorylation of S6K1 at the
mTORC1 dependent site Thr389, a residue critical to S6K1
activation [42]. S6K1 Thr389 phosphorylation was higher in the
control and overloaded PLN of PTEN2/2 mice (PTEN+/+- Con
PLN = 0.6260.14, Abl PLN = 1.3760.21; PTEN2/2 - Con
PLN = 2.2760.26, Abl PLN = 3.7560.31; Figure 5). However,
the difference (delta) between the overloaded and control muscle
Figure 3. Alterations in striated muscle mass in PTEN knockout mice. The mass of select striated muscles relative to body mass was
determined for PTEN+/+ (n = 19) and PTEN2/2 mice (n = 20). * Indicates significantly different from wild type (p,0.05).
doi:10.1371/journal.pone.0011624.g003
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was identical. There were no significant differences between
groups for the other muscles.
S6K1 Thr389 Phosphorylation Following Acute Resistance
Exercise
Acute resistance exercise is a more physiological model of
muscle loading than synergist ablation. Therefore, the phosphor-
ylation of S6K1 at Thr389 1 hour after an acute bout of resistance
exercise was determined in PTEN+/+ and PTEN2/2 mice. As
previously reported [43], the change in phosphorylation of S6K1
was significantly higher in the TA and EDL than in the SOL with
the PLN muscle seeing,50% of the activation seen in the TA and
EDL (Figure 6). However, there was no significant difference in
the phosphorylation of S6K1 between the PTEN+/+ and PTEN2/
2 mice in any muscle analysed.
Discussion
The present study demonstrates that resistance exercise does not
alter the activity of the IGF-1 receptor or result in recruitment of
PI3K to IRS1/2. Further, even though complete knockout of
PTEN in muscle led to a reduction in insulin-stimulated
phosphorylation of PKB in the EDL and increased wet mass in
the TA and heart, the response to overload was unaltered. It is
interesting to note that even though skeletal muscle is highly
insulin sensitive and has a low incidence of transformation, PTEN
is expressed at a substantially lower level in skeletal muscle than
any other tissue analysed. These data suggest that growth factor
signalling through PI(3,4,5)P3, and by extension PKB, does not
play a significant role in normal skeletal muscle hypertrophy but
may play a role in maintaining developmental growth and insulin
sensitivity.
Insulin and insulin-like growth factor activation of mTORC1 is
dependent on the activation of the IGF-1 receptor [44], the
generation of PI(3,4,5)P3 at the membrane, and the subsequent
activation of PKB [45,46]. PI(3,4,5)P3 is primarily generated by the
class IA phosphoinositide 3-kinases following recruitment to the
membrane through the association of the regulatory p85 subunit
with membrane-associated phosphotyrosine residues [47]. IRS1
and IRS2 are the predominant membrane-associated scaffolds for
PI3K, with IRS1 associated p85 accounting for up to as much as
70% of total cellular PI3K activity [47]. We found no increase in
IGF-1 receptor tyrosine phosphorylation or IRS1/2 associated p85
following resistance exercise and, from 30 minutes, p85 associated
with IRS1/2 was reduced. As p85 can bind to other phosphopro-
teins [48] we also assessed phosphotyrosine associated p85 at 0 hr,
0.5 hrs and 18 hrs post stimulation and found no significant change
in this measure. The increase in mTORC1 activity and PKB
Figure 4. PTEN knockout in striated muscle does not alter muscle hypertrophy in response to overload. The plantaris (PLN) and soleus
(SOL) muscles were overloaded by ablation of the gastrocnemius muscle for 10 days. In a separate group of animals the extensor digitorum longus
(EDL) muscle was overloaded by removal of the tibialis anterior muscle for 4 weeks. Data presented are mean muscle mass from the control (Con) and
ablated (Abl) legs divided by the body mass of the animals for n = 6 animals. * indicates significantly larger muscle mass than the controls.
doi:10.1371/journal.pone.0011624.g004
PIP3-Independent Hypertrophy
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phosphorylation in the absence of IRS1/2 associated p85 is
consistent with other models of contraction in which PKB is
activated independent of any increase in tyrosine phosphorylation of
the insulin receptor or IRS1 [49,50]. Interestingly, O’Neil et al have
shown that when mouse EDL muscles are stretched ex vivo for 60
minutes, mTORC1 is activated in a wortmannin insensitive manner
[50], whereas Sakamoto et al. [49], demonstrated that the activation
of PKB by endurance exercise is wortmannin sensitive. This
indicates that exercise-induced accumulation of PI(3,4,5)P3 was
required for the activation of PKB following some types of
contraction. The absence of PI3K activation together with the
requirement for PI(3,4,5,)P3 observed by Sakamoto suggested that
inactivation of PTEN [51] could be important in contraction
mediated PKB activation.
To determine whether PI(3,4,5)P3 accumulation was important
for resistance exercise-induced signalling to mTORC1 we
therefore sought to determine the effect of muscle-specific
knockout of the 3-phosphatase PTEN. There are some disparities
between the current data and previously published work on MCK-
Cre+/2 PTEN2/2 mice. For instance, we observed a 10%
increase in heart mass in the absence of PTEN compared to the
,50% increase reported by Crackower et al [22]. Interestingly,
the mass of the hearts in our control animals was approximately
10% larger than that reported by Crackower et al [22] suggesting
that the disparity might be the result of differences in the strain
background of the mice. The greatest difference between the
current work and the literature is the substantially lower PTEN
levels observed in muscle. Unlike Wijesekara et al, we found very
little PTEN in wild type skeletal muscle [23]. In fact, compared to
other organs, wild type muscle appeared to already be PTEN null.
We confirmed the low levels of PTEN in muscle by western blot in
rats and 5 other mouse strains, using 3 different antibodies and
then validated these data with immunohistochemistry. Even
though we looked at 5 mouse strains, it is still possible that the
disparity in PTEN expression is the result of differences in the
background strain of the transgenic line. There is evidence that the
genetic background of a transgenic line can have a dramatic effect
on phenotype [52]. For instance, altering the targeting subunit of
the phosphatase PP1 leads to either an obese insulin resistant
phenotype [53] or a normal phenotype depending on the donor
background [54] even though both studies backcrossed onto the
C57Bl/6 line. However, we believe that a more likely explanation
could be the development of new antibodies that are more specific
and technical differences in the histochemistry.
While the basal level of PTEN was lower than previously
reported, the effect of PTEN knockout on insulin sensitivity was
similar. Several previous reports have demonstrated a decrease in
insulin sensitivity following loss of PTEN [23,28]. Consistent with
this, insulin-stimulated phosphorylation of PKB in the EDL was
shifted to the right in the PTEN2/2 mice (Figure S2).
Interestingly, the effect was not seen in the soleus muscle even
though the basal expression of PTEN and the percent decrease in
PTEN were greater. This suggests that fast skeletal muscle is more
metabolically sensitive to loss of PTEN than slow muscle even
though slow muscle has higher insulin sensitivity.
Since previous studies have shown that increasing PKB activity/
expression leads to muscle growth in adult skeletal muscle [6,7],
we had expected that the growth response of muscle from PTEN
null animals would have been greater due to greater PKB
signalling. Indeed, we found significant increases in PKB Thr308
Figure 5. Muscle specific PTEN knockout alters PKB and S6K1 signalling in select muscles. The phosphorylation of PKB and S6K1 were
determined in control muscles and muscles following overload of the plantaris (PLN) and soleus (SOL) muscles, by ablation of the gastrocnemius
muscle for 10 days or the extensor digitorum longus (EDL) muscle by removal of the tibialis anterior muscle for 4 weeks. (A) Phosphorylation of PKB at
Thr308 and its (B) quantification as well as (C) the phosphorylation of S6K1 at Thr389 and (D) its quantification. Data presented are mean 6 SEM for
n = 6 animals. * indicates significantly different than the wild type and { indicates significantly different than control.
doi:10.1371/journal.pone.0011624.g005
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phosphorylation in the overloaded PLN. However, load induced
growth was normal in PTEN null animals suggesting a dissociation
between PI3K/PKB signalling and hypertrophy. This is likely
because overload simultaneously activates AMPKa1 and
AMPKa1 antagonises PKB phosphorylation of TSC2 [40,55].
Therefore, while PKB phosphorylation is increased, there is no
greater muscle growth. In support of this hypothesis, Mounier et al
[56] showed that knocking out AMPKa1 leads to enhanced
muscle growth following ablation. Therefore, activation of
AMPKa1 during hypertrophy limits the activation of mTORC1
and reduces muscle growth. Furthermore, previous transgenic
work has clearly demonstrated that AMPK can limit tumorigenesis
in PTEN hypomorphic mice suggesting that a similar mechanism
is at work during overload hypertrophy [57]. Crossing muscle
specific PTEN knockouts with the AMPKa1 knockouts would
allow us to directly test this hypothesis. However, there is evidence
that the activation of AMPKa1 is not the only mechanism of
action. Specifically, the fact that S6K1 Thr389 phosphorylation is
elevated in the PLN in parallel with increased PKB Thr308
phosphorylation suggests that the inhibitory effect of AMPK on
mTORC1 is not the only mechanism at work.
While the increase in PI3K/PKB activity in the overloaded PLN
muscle did not lead to an increase in muscle growth, it could have
led to alterations in phenotype that were not measured. During
overload hypertrophy, there is an,19% increase in the capillary to
fiber ratio in the first 15 days [58]. Plyley et al [58] suggested that the
correlation between the increased fiber area and capillarisation are
indicative of a common factor regulating both processes. Activation
of PKB leads to an increase in the expression of VEGF and a
resultant increase in capillary density and blood flow [59].
Therefore, while the increased activation of PKB in the overloaded
PLN muscle of the PTEN2/2 mice did not enhance muscle growth,
muscle blood flow may have been improved. Of note, there was
only an increase in PKB phosphorylation in the overloaded muscle
with the altered recruitment pattern (PLN muscle). Since changing
recruitment could lead to greater metabolic stress and therefore
greater angiogenesis, this finding is consistent with the hypothesis
that the increase in PI3K/PKB activity is important in increasing
blood flow to the muscle following overload.
In summary, loss of PTEN in skeletal muscle leads to an
increase in the mass of selected muscles during development.
However, the enhanced PI3K/PKB signalling following ablation
does not lead to significant increases in muscle mass. This suggests
that growth factor activation of PI3K/PKB plays a limited direct
role in the hypertrophy of adult skeletal muscle.
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